Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
2,599,170
-
Share change
-
+533,034
-
Total reported value
-
$115,244,636
-
Price per share
-
$43.81
-
Number of holders
-
99
-
Value change
-
+$23,167,842
-
Number of buys
-
54
-
Number of sells
-
34
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2021
As of 31 Dec 2021 ISHARES TR - GENOMICS IMMUN (IDNA) had 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,599,170 shares of stock of the company.
Largest 10 holders included UBS Group AG, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Thrivent Financial for Lutherans, JANE STREET GROUP, LLC, Wharton Business Group, LLC, Wealthcare Advisory Partners LLC, LPL Financial LLC, CITADEL ADVISORS LLC, and ROYAL BANK OF CANADA.
This table shows 101 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.